Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
AbbVie Projects $3B Sales For HCV Cocktail, But Shares Fall 3%
Seeking Alpha
Mon, 02/2/15 - 03:28 pm
AbbVie
hepatitis C
Viekira Pak
Can The Biotech Sector See Stellar Results For 2015 Amid Price Wars?
Bidness Etc.
Mon, 02/2/15 - 09:57 am
drug pricing
biotech
Gilead Sciences
AbbVie
AbbVie Announces Top-line Results from Phase 3 Study of All-Oral Treatment for Hepatitis C in Japan
Yahoo
Sat, 01/31/15 - 10:06 am
AbbVie
Japan
hepatitis C
Abbvie Expects $3B In Hepatitis C Drug Sales And 40% Of Insured Customers
Forbes
Fri, 01/30/15 - 11:18 am
AbbVie
hepatitis C
Viekira Pak
AbbVie shares up 2.6% as company beats profit, sales estimates
Marketwatch
Fri, 01/30/15 - 08:30 am
AbbVie
earnings
Gilead Sciences, Inc. Continues To Reign Over The Hepatitis C Market
Bidness Etc.
Fri, 01/30/15 - 08:05 am
Gilead Sciences
AbbVie
Harvoni
Sovaldi
hepatitis C
Viekira Pak
Gilead Sciences, Inc. Harvoni Gets Preferred Status From UnitedHealth Group (UNH)
Bidness Etc.
Thu, 01/29/15 - 11:11 am
Gilead Sciences
hepatitis C
United Health
Harvoni
AbbVie
Can Gilead Beat AbbVie At Its Own Game?
Seeking Alpha
Thu, 01/29/15 - 07:28 am
Gilead
AbbVie
hepatitis C
Harvoni
Sovaldi
Viekira Pak
Express Scripts
AbbVie Hepatitis C Drug Will Be Focus of Profit Report — Earnings Preview
WSJ Online
Tue, 01/27/15 - 04:32 pm
AbbVie
earnings
Viekira Pak
hepatitis C
Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead
Motley Fool
Tue, 01/27/15 - 10:02 am
Pfizer
M&A
AstraZeneca
Shire
AbbVie
Isis Pharmaceuticals
Gilead Sciences, Inc.’s (GILD) Harvoni Prescriptions Drop 1.8%
Bidness Etc.
Mon, 01/26/15 - 11:46 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Viekira Pak
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales
Investors.com
Wed, 01/21/15 - 05:42 pm
Gilead Sciences
AbbVie
hepatitis C
drug pricing
Viekira Pak
Harvoni
Sovaldi
AbbVie Innovation Center Opens at the University of Illinois-Urbana Research Park
Yahoo
Tue, 01/20/15 - 01:49 pm
AbbVie
innovation
AbbVie Inc (ABBV) Expected To Post Single-Digit Growth In Earnings, Revenue For 4Q
Bidness Etc.
Tue, 01/20/15 - 09:30 am
AbbVie
earnings
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
AbbVie Strikes Hepatitis C Discount Deal With AIDS Drug Programs
Bloomberg
Mon, 01/19/15 - 12:06 pm
AbbVie
hepatitis C
AIDS
HIV
Viekira Pak
Aetna backs Gilead's hepatitis C treatment, gets discount
Reuters
Sat, 01/17/15 - 11:03 am
Aetna
Gilead Sciences
hepatitis C
AbbVie
Sovaldi
Harvoni
Viekira Pak
Abandonment rates indicate room in the anti-TNF market
Medical Marketing and Media
Fri, 01/16/15 - 08:52 am
anti-TNF
JNJ
Remicade
Humira
AbbVie
Biogen Idec
AbbVie’s hepatitis C drug gets European approval for sale
Marketwatch
Fri, 01/16/15 - 08:45 am
AbbVie
hepatitis C
Europe
Viekira Pak
Receptos Shopping For A Partner With Strong Data In Hand
Seeking Alpha
Thu, 01/15/15 - 12:05 pm
Receptos
AbbVie
Biogen Idec
JNJ
Novartis
RPC1063
ulcerative colitis
multiple sclerosis
Pages
« first
‹ previous
…
58
59
60
61
62
63
64
65
66
…
next ›
last »